Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant

Clinical trial NCT06701396 · RECRUITING

Trial details

NCT number: NCT06701396
Sponsor: Vanda Pharmaceuticals
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Sleep Wake Disorders Sleep Disorders, Circadian Rhythm Chronobiology Disorders Gene Mutations and Other Alterations Nec

Start date: 2024-10-08
Primary completion: 2025-06-30
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.